Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells

FASEB Journal

Volumn 25, Issue 8, 2011, Pages 2831-2842

  Piedfer, Marion ^a,b,c   Dauzonne, Daniel ^d   Tang, Ruoping ^e   N'Guyen, Juliette ^f   Billard, Christian ^a,b,c   Bauvois, Brigitte ^a,b,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CNRS   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f Hôpital Cochin ^*  (France)

Author keywords

AML; Antibody; APN; Bcl 2 family; Inhibitor

Indexed keywords

MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; PROTEIN BCL 2;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; BONE MARROW TUMOR; CELL CYCLE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD13; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL PROLIFERATION; CELL SURVIVAL; ENZYME INHIBITORS; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MAP KINASE KINASE 1; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; POLY(ADP-RIBOSE) POLYMERASES; PROTEASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; U937 CELLS; YOUNG ADULT;

EID: 80051679604     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-181396     Document Type: Article

References (59)

1. Bauvois, B., and Dauzonne, D. (2006) Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects. Med. Res. Rev. 26, 88-130 (Pubitemid 43986471)
2. Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R. A., Shapiro, L. H., Arap, W., and Ruoslahti, E. (2000) Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 60, 722-727 (Pubitemid 30094573)
3. Bhagwat, S. V., Lahdenranta, J., Giordano, R., Arap, W., Pasqualini, R., and Shapiro, L. H. (2001) CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 97, 652-659 (Pubitemid 32113397)
4. Saiki, I., Fujii, H., Yoneda, J., Abe, F., Nakajima, M., Tsuruo, T., and Azuma, I. (1993) Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer 54, 137-143 (Pubitemid 23137011)
5. Ino, K., Goto, S., Okamoto, T., Nomura, S., Nawa, A., Isobe, K., Mizutani, S., and Tomoda, Y. (1994) Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity. Jpn. J. Cancer Res. 85, 927-933 (Pubitemid 24294751)
6. Hashida, H., Takabayashi, A., Kanai, M., Adachi, M., Kondo, K., Kohno, N., Yamaoka, Y., and Miyake, M. (2002) Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology 122, 376-386 (Pubitemid 34116989)
7. Mina-Osorio, P., Shapiro, L. H., and Ortega, E. (2006) CD13 in cell adhesion: aminopeptidase N (CD13) mediates homotypic aggregation of monocytic cells. J. Leukoc. Biol. 79, 719-730 (Pubitemid 44835604)
8. Mina-Osorio, P., Winnicka, B., O'Conor, C., Grant, C. L., Vogel, L. K., Rodriguez-Pinto, D., Holmes, K. V., Ortega, E., and Shapiro, L. H. (2008) CD13 is a novel mediator of monocytic/endothelial cell adhesion. J. Leukoc. Biol. 84, 448-459
9. Lai, A., Ghaffari, A., and Ghahary, A. (2010) Inhibitory effect of anti-aminopeptidase N/CD13 antibodies on fibroblast migration. Mol. Cell. Biochem. 343, 191-199
10. Lendeckel, U., Kahne, T., Riemann, D., Neubert, K., Arndt, M., and Reinhold, D. (2000) Review: the role of membrane peptidases in immune functions. Adv. Exp. Med. Biol. 477, 1-24 (Pubitemid 32173985)
11. Breljak, D., Gabrilovac, J., and Boranic, M. (2003) Aminopeptidase N/CD13 and haematopoietic cells. Haema 6, 453-461 (Pubitemid 37362684)
12. Mina-Osorio, P. (2008) The moonLighting enzyme CD13: old and new functions to target. Trends Mol. Med. 14, 361-371
13. Cowburn, A. S., Sobolewski, A., Reed, B. J., Deighton, J., Murray, J., Cadwallader, K. A., Bradley, J. R., and Chilvers, E. R. (2006) Aminopeptidase N (CD13) regulates tumor necrosis Factor-alpha-induced apoptosis in human neutrophils. J. Biol. Chem. 281, 12458-12467 (Pubitemid 43855332)
14. Mason, K. D., Juneja, S. K., and Szer, J. (2006) The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis? Blood Rev. 20, 71-82
15. King, M. E., and Rowe, J. M. (2007) Recent Developments in acute myelogenous leukemia therapy. Oncologist 12(Suppl. 2), 14-21
16. Plesa, C., Chelghoum, Y., Plesa, A., Elhamri, M., Tigaud, I., Michallet, M., Dumontet, C., and Thomas, X. (2008) Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience. Cancer 112, 572-580 (Pubitemid 351192915)
17. Wickstrom, M., Larsson, R., Nygren, P., and Gullbo, J. (2011) Aminopeptidase N (CD13) as a target for cancer chemotherapy. Cancer Sci. 102, 501-508
18. Bauvois, B., Puiffe, M. L., Bongui, J. B., Paillat, S., Monneret, C., and Dauzonne, D. (2003) Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13. J. Med. Chem. 46, 3900-3913 (Pubitemid 37034139)
19. Fazi, F., Racanicchi, S., Zardo, G., Starnes, L. M., Mancini, M., Travaglini, L., Diverio, D., Ammatuna, E., Cimino, G., Lo-Coco, F., Grignani, F., and Nervi, C. (2007) Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 12, 457-466 (Pubitemid 350046404)
20. Bauvois, B., Van Weyenbergh, J., Rouillard, D., and Wietzerbin, J. (1996) TGF-beta 1-stimulated adhesion of human mononuclear phagocytes to fibronectin and laminin is abolished by IFN-γ: dependence on alpha 5 beta 1 and beta 2 integrins. Exp. Cell. Res. 222, 209-217
21. Bhardwaj, A., Sethi, G., Vadhan-Raj, S., Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A. S., Shishodia, S., and Aggarwal, B. B. (2007) Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109, 2293-2302 (Pubitemid 46425866)
22. Bauvois, B., Djavaheri-Mergny, M., Rouillard, D., Dumont, J., and Wietzerbin, J. (2000) Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells. Oncogene 19, 265-272 (Pubitemid 30077223)
23. Quiney, C., Billard, C., Faussat, A. M., Salanoubat, C., Ensaf, A., Nait-Si, Y., Fourneron, J. D., and Kolb, J. P. (2006) Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia. Leukemia 20, 491-497 (Pubitemid 43291749)
24. Sanceau, J., Boyd, D. D., Seiki, M., and Bauvois, B. (2002) Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-κB. J. Biol. Chem. 277, 35766-35775
25. Favaloro, E. J., Bradstock, K. F., Kabral, A., Grimsley, P., Zowtyj, H., and Zola, H. (1988) Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33. Br. J. Haematol. 69, 163-171
26. Ashmun, R. A., and Look, A. T. (1990) Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood 75, 462-469 (Pubitemid 20035279)
27. Platanias, L. C. (2003) MAP kinase signaling pathways and hematologic malignancies. Blood 101, 4667-4679
28. Grandage, V. L., Gale, R. E., Linch, D. C., and Khwaja, A. (2005) PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-κB, MAP kinase and p53 pathways. Leukemia 19, 586-594 (Pubitemid 40521164)
29. Xie, J., Qian, J., Yang, J., Wang, S., Freeman, M. E., 3rd, and Yi, Q. (2005) Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells. Exp Hematol 33, 564-572 (Pubitemid 40592173)
30. Rahmani, M., Yu, C., Reese, E., Ahmed, W., Hirsch, K., Dent, P., and Grant, S. (2003) Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21(CIP1/WAF1) induction rather than AKT inhibition. Oncogene 22, 6231-6242 (Pubitemid 37281653)
31. Nguyen, J., Gogusev, J., Knapnougel, P., and Bauvois, B. (2006) Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-α in human monocytes. Immunol. Lett. 106, 34-41 (Pubitemid 44093049)
32. Broker, L. E., Kruyt, F. A., and Giaccone, G. (2005) Cell death independent of caspases: a review. Clin. Cancer Res. 11, 3155-3162 (Pubitemid 40627860)
33. Wang, Z. B., Liu, Y. Q., and Cui, Y. F. (2005) Pathways to caspase activation. Cell Biol. Int. 29, 489-496
34. Sun, X. M., MacFarlane, M., Zhuang, J., Wolf, B. B., Green, D. R., and Cohen, G. M. (1999) Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274, 5053-5060
35. Engels, I. H., Stepczynska, A., Stroh, C., Lauber, K., Berg, C., Schwenzer, R., Wajant, H., Janicke, R. U., Porter, A. G., Belka, C., Gregor, M., Schulze-Osthoff, K., and Wesselborg, S. (2000) Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 19, 4563-4573
36. Maddika, S., Ande, S. R., Panigrahi, S., Paranjothy, T., Weglarczyk, K., Zuse, A., Eshraghi, M., Manda, K. D., Wiechec, E., and Los, M. (2007) Cell survival, cell death, and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist. Updat. 10, 13-29 (Pubitemid 46636381)
37. Fujita, N., and Tsuruo, T. (1998) Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biochem. Biophys. Res. Commun. 246, 484-488 (Pubitemid 28412628)
38. Sordet, O., Bettaieb, A., Bruey, J. M., Eymin, B., Droin, N., Ivarsson, M., Garrido, C., and Solary, E. (1999) Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells. Cell Death Differ. 6, 351-361 (Pubitemid 29186879)
39. Zhao, S., Konopleva, M., Cabreira-Hansen, M., Xie, Z., Hu, W., Milella, M., Estrov, Z., Mills, G. B., and Andreeff, M. (2004) Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias. Leukemia 18, 267-275 (Pubitemid 38240042)
40. Griffin, J. D., Ritz, J., Nadler, L. M., and Schlossman, S. F. (1981) Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J. Clin. Invest. 68, 932-941 (Pubitemid 11023521)
41. Favaloro, E. J. (1991) CD-13 ('gp150'; aminopeptidase-N): co-expression on endothelial and haemopoietic cells with conservation of functional activity. Immunol. Cell. Biol. 69, 253-260
42. Grujic, M., and Renko, M. (2002) Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions. Cancer Lett. 182, 113-119 (Pubitemid 34621173)
43. Mina-Osorio, P., and Ortega, E. (2005) Aminopeptidase N (CD13) functionally interacts with FcRs in human monocytes. J. Leukoc. Biol. 77, 1008-1017 (Pubitemid 40770854)
44. Riemann, D., Tcherkes, A., Hansen, G. H., Wulfaenger, J., Blosz, T., and Danielsen, E. M. (2005) Functional co-localization of monocytic aminopeptidase N/CD13 with the Fc γ receptors CD32 and CD64. Biochem. Biophys. Res. Commun. 331, 1408-1412 (Pubitemid 40692512)
45. Santos, A. N., Langner, J., Herrmann, M., and Riemann, D. (2000) Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes. Cell. Immunol. 201, 22-32 (Pubitemid 30337705)
46. Martelli, A. M., Nyakern, M., Tabellini, G., Bortul, R., Tazzari, P. L., Evangelisti, C., and Cocco, L. (2006) Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 20, 911-928 (Pubitemid 43797279)
47. Bernardi, P., and Rasola, A. (2007) Calcium and cell death: the mitochondrial connection. Subcell. Biochem. 45, 481-506
48. Lohn, M., Mueller, C., Thiele, K., Kahne, T., Riemann, D., and Langner, J. (1997) Aminopeptidase N-mediated signal transduction and inhibition of proliferation of human myeloid cells. Adv. Exp. Med. Biol. 421, 85-91 (Pubitemid 27432657)
49. Gredmark, S., Britt, W. B., Xie, X., Lindbom, L., and Soderberg-Naucler, C. (2004) Human cytomegalovirus induces inhibition of macrophage differentiation by binding to human aminopeptidase N/CD13. J. Immunol. 173, 4897-4907 (Pubitemid 39387771)
50. Scaffidi, C., Schmitz, I., Zha, J., Korsmeyer, S. J., Krammer, P. H., and Peter, M. E. (1999) Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274, 22532-22538
51. Martelli, A. M., Cocco, L., Capitani, S., Miscia, S., Papa, S., and Manzoli, F. A. (2007) Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis. Eur. J. Histochem. 51(Suppl. 1), 125-131
52. Park, C., Jin, C. Y., Kim, G. Y., Choi, I. W., Kwon, T. K., Choi, B. T., Lee, S. J., Lee, W. H., and Choi, Y. H. (2008) Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK. Toxicol. Appl. Pharmacol. 227, 219-228 (Pubitemid 351231936)
53. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. J. (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87, 619-628 (Pubitemid 26386936)
54. Bremer, E., van Dam, G., Kroesen, B. J., de Leij, L., and Helfrich, W. (2006) Targeted induction of apoptosis for cancer therapy: current progress and prospects. Trends Mol. Med. 12, 382-393 (Pubitemid 44164637)
55. Song, G., Chen, G. G., Hu, T., and Lai, P. B. (2010) Bid Stands at the crossroad of stress-response pathways. Curr. Cancer Drug Targets 10, 584-592
56. Afonina, I. S., Cullen, S. P., and Martin, S. J. (2010) Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B. Immunol. Rev. 235, 105-116
57. Chowdhury, I., Tharakan, B., and Bhat, G. K. (2008) Caspases - an update. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 151, 10-27
58. Bulat, N., and Widmann, C. (2009) Caspase substrates and neurodegenerative diseases. Brain Res. Bull. 80, 251-267
59. Haraguchi, N., Ishii, H., Mimori, K., Tanaka, F., Ohkuma, M., Kim, H. M., Akita, H., Takiuchi, D., Hatano, H., Nagano, H., Barnard, G. F., Doki, Y., and Mori, M. (2010) CD13 is a therapeutic target in human liver cancer stem cells. J. Clin. Invest. 120, 3326-3339